Chief Financial Officer

Senior Vice President CMC Development

New data from Helios-B Phase 3 study demonstrate lower rates of gastrointestinal events in ATTR-CM patients treated with Vutrisiran

Alnylam Pharmaceuticals Says Amvuttra Reduces Gastrointestinal Events in Study

Wall Street Bets Against Chaos, Again

New Data from HELIOS-B Phase 3 Study Demonstrate Lower Rates of Gastrointestinal Events in ATTR-CM Patients Treated with Vutrisiran

Director, Finance Operations Digital Enablement

Alnylam Pharmaceuticals is a leader in innovative RNA interference medicines, and they are seeking a Director of Finance Operations Digital Enablement. This role will provide critical leadership in embedding an automation and data-driven culture within Finance operations, focusing on driving and scaling automation and analytics initiatives in collaboration with IT.

Senior Vice President, Finance

Finance Director, Partner & Emerging Markets

Director of Finance, Global Rare Business Unit

Senior Director Finance

Sign up with Google

Sign in with Google